2018 专家共识:高尿酸血症和高心血管风险患者的诊断和治疗

2018-10-30 国外心血管相关专家小组(统称) Cardiol J. 2018;25(5):545-563.

本文主要为临床医生在治疗高尿酸血症同时合并高心血管风险患者时提供指导建议,主要内容涉及高尿酸血症的定义和流行病学,高尿酸血症和痛风的管理,高尿酸血症在心血管疾病方面的病理生理作用,高尿酸血症及其并发症,高尿酸血症和不良事件,高尿酸血症的治疗和心血管结局,高尿酸血症和高心血管风险的管理策略等。

中文标题:

2018 专家共识:高尿酸血症和高心血管风险患者的诊断和治疗

英文标题:

Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk.

发布日期:

2018-10-30

简要介绍:

本文主要为临床医生在治疗高尿酸血症同时合并高心血管风险患者时提供指导建议,主要内容涉及高尿酸血症的定义和流行病学,高尿酸血症和痛风的管理,高尿酸血症在心血管疾病方面的病理生理作用,高尿酸血症及其并发症,高尿酸血症和不良事件,高尿酸血症的治疗和心血管结局,高尿酸血症和高心血管风险的管理策略等。

拓展指南:高尿酸相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 专家共识:高尿酸血症和高心血管风险患者的诊断和治疗)] GetToolGuiderByIdResponse(projectId=1, id=6bdfa1c001661e72, title=2018 专家共识:高尿酸血症和高心血管风险患者的诊断和治疗, enTitle=Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk., guiderFrom=Cardiol J. 2018;25(5):545-563., authorId=null, author=, summary=本文主要为临床医生在治疗高尿酸血症同时合并高心血管风险患者时提供指导建议,主要内容涉及高尿酸血症的定义和流行病学,高尿酸血症和痛风的管理,高尿酸血症在心血管疾病方面的病理生理作用,高尿酸血症及其并发症,高尿酸血症和不良事件,高尿酸血症的治疗和心血管结局,高尿酸血症和高心血管风险的管理策略等。 , cover=, journalId=null, articlesId=null, associationId=738, associationName=国外心血管相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Tue Oct 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>本文主要为临床医生在治疗高尿酸血症同时合并高心血管风险患者时提供指导建议,主要内容涉及高尿酸血症的定义和流行病学,高尿酸血症和痛风的管理,高尿酸血症在心血管疾病方面的病理生理作用,高尿酸血症及其并发症,高尿酸血症和不良事件,高尿酸血症的治疗和心血管结局,高尿酸血症和高心血管风险的管理策略等。</div> <div><br> </div>拓展指南:<strong>与<font color=red>高尿酸</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=8efc91c0015a94bd" title="2018 台湾多学科共识:痛风及高尿酸血症的管理" target=_blank>2018 台湾多学科共识:痛风及高尿酸血症的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=01f4f1c00151a207" title="中国高尿酸血症与相关疾病诊疗多学科专家共识(英文版)" target=_blank>中国高尿酸血症与相关疾病诊疗多学科专家共识(英文版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c90d11c001a89993" title="中国慢性肾脏病患者合并高尿酸血症诊治专家共识" target=_blank>中国慢性肾脏病患者合并高尿酸血症诊治专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=49edf1c001a831fd" title="中国高尿酸血症相关疾病诊疗多学科专家共识" target=_blank>中国高尿酸血症相关疾病诊疗多学科专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=e87e71c001a66100" title="中国肾脏疾病高尿酸血症诊治的实践指南(2017版)" target=_blank>中国肾脏疾病高尿酸血症诊治的实践指南(2017版)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E9%AB%98%E5%B0%BF%E9%85%B8" target=_blank>有关高尿酸更多指南</a></ul>, tagList=[TagDto(tagId=4057, tagName=高尿酸血症), TagDto(tagId=1567, tagName=心血管风险)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7754, appHits=914, showAppHits=19, pcHits=5318, showPcHits=2377, likes=117, shares=28, comments=3, approvalStatus=1, publishedTime=Sun Nov 11 21:46:43 CST 2018, publishedTimeString=2018-10-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Nov 11 21:46:43 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:31:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 专家共识:高尿酸血症和高心血管风险患者的诊断和治疗)])
2018 专家共识:高尿酸血症和高心血管风险患者的诊断和治疗
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=974222, encodeId=edc49e4222d3, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08762170827, createdName=12050572m40暂无昵称, createdTime=Wed Jun 16 22:13:41 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907358, encodeId=979090e35873, content=分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3e1436967, createdName=1269297273, createdTime=Sat Dec 12 18:36:06 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2021-06-16 12050572m40暂无昵称

    非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=974222, encodeId=edc49e4222d3, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08762170827, createdName=12050572m40暂无昵称, createdTime=Wed Jun 16 22:13:41 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907358, encodeId=979090e35873, content=分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3e1436967, createdName=1269297273, createdTime=Sat Dec 12 18:36:06 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2020-12-12 1269297273

    分享

    0